Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Vaccine|June 18, 2024
Proceedings of the dengue endgame summit: Imagining a world with dengue controlAdam D Wegman, Shirin Kalimuddin, Ernesto T A Marques, et al.
Hypertension (Dallas, Tex. : 1979)|May 3, 2021
Team Science: American Heart Association's Hypertension Strategically Focused Research Network ExperienceMark K Santillan, Richard C Becker, David A Calhoun, et al.
NPJ Vaccines|February 15, 2024
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent miceIn-Jeong Kim, Michael P Tighe, Paula A Lanthier, et al.
Ebiomedicine|April 22, 2020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infectionAdam T Waickman, Gregory D Gromowski, Wiriya Rutvisuttinunt, et al.
Plos Neglected Tropical Diseases|October 5, 2018
Development of standard clinical endpoints for use in dengue interventional trialsKay M Tomashek, Bridget Wills, Lucy Chai See Lum, et al.
Plos Pathogens|August 4, 2017
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Heather L Friberg, et al.
The New England Journal of Medicine|May 27, 2021
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in AdolescentsRobert W Frenck, Nicola P Klein, Nicholas Kitchin, et al.
Science Translational Medicine|December 15, 2017
Durability and correlates of vaccine protection against Zika virus in rhesus monkeysPeter Abbink, Rafael A Larocca, Kittipos Visitsunthorn, et al.
Plos Pathogens|May 2, 2022
Beneath the surface: Amino acid variation underlying two decades of dengue virus antigenic dynamics in Bangkok, ThailandAngkana T Huang, Henrik Salje, Ana Coello Escoto, et al.
The New England Journal of Medicine|December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineFernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
Pageof 30